Values First Advisors, Inc. Bio Line Rx Ltd. Transaction History
Values First Advisors, Inc.
- $169 Million
- Q1 2024
A detailed history of Values First Advisors, Inc. transactions in Bio Line Rx Ltd. stock. As of the latest transaction made, Values First Advisors, Inc. holds 203,633 shares of BLRX stock, worth $111,998. This represents 0.13% of its overall portfolio holdings.
Number of Shares
203,633
Previous 52,168
290.34%
Holding current value
$111,998
Previous $81,000
181.48%
% of portfolio
0.13%
Previous 0.05%
Shares
3 transactions
Others Institutions Holding BLRX
# of Institutions
35Shares Held
1.4MCall Options Held
24.1KPut Options Held
184K-
Morgan Stanley New York, NY291KShares$160,2440.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA205KShares$112,7020.0% of portfolio
-
Lpl Financial LLC Fort Mill, SC100KShares$55,1770.0% of portfolio
-
Atria Wealth Solutions, Inc. New York, NY99.3KShares$54,6330.0% of portfolio
-
Pvg Asset Management Corp Golden, CO61.8KShares$34,0120.49% of portfolio
About BioLineRx Ltd.
- Ticker BLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 61,524,500
- Market Cap $33.8M
- Description
- BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. The company develops Motixafortide, a peptide, which has completed Phase 3 clinical trials for the treatment of autologous stem cell mobilization and Phase 2a clinical trials for the treatment of pancreatic cancer; and that is in Phase 2 clinical trials ...